PMID- 35649224 OWN - NLM STAT- MEDLINE DCOM- 20220603 LR - 20230821 IS - 1538-943X (Electronic) IS - 1058-2916 (Print) IS - 1058-2916 (Linking) VI - 68 IP - 6 DP - 2022 Jun 1 TI - Right Ventricular Dysfunction is Associated with Increased Mortality in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019. PG - 772-778 LID - 10.1097/MAT.0000000000001666 [doi] AB - Respiratory failure caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is associated with mortality. Patients unresponsive to conventional therapy may benefit from temporary venovenous extracorporeal membrane oxygenation (VV-ECMO). We investigated clinical and echocardiographic characteristics, particularly, right ventricular dysfunction, with survival in patients with respiratory failure caused by SARS-CoV-2. We performed a single-center retrospective cohort study of patients requiring VV-ECMO for respiratory failure from COVID-19 infection between January 2020 and December 2020. Demographics, comorbidities, laboratory parameters, and echocardiographic features of left and right ventricular (LV/RV) function were compared between patients who survived and those who could not be weaned from VV-ECMO. In addition, we evaluated outcomes in a separate population managed with venoarterial extracorporeal membrane oxygenation (VA-ECMO). In total, 10/17 patients failed to wean from VV-ECMO and died in the hospital on average 41.5 +/- 10.9 days post admission. Seven were decannulated (41%) and survived to hospital discharge. There were no significant differences in demographics, comorbidities, and laboratory parameters between groups. Moderate to severe RV dysfunction was significantly more in those who died (8/10, 80%) compared to survivors (0/7, 0%) (p = 0.002). Patients supported with VA-ECMO had superior survival with 5/9 patients (56%) decannulated and discharged. Moderate to severe RV dysfunction is associated with increased mortality in patients with respiratory failure requiring VV-ECMO for COVID-19. CI - Copyright (c) ASAIO 2022. FAU - Maharaj, Valmiki AU - Maharaj V AUID- ORCID: 0000-0003-0442-0021 AD - From the Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, Minnesota. FAU - Alexy, Tamas AU - Alexy T AUID- ORCID: 0000-0001-8381-6299 AD - From the Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, Minnesota. FAU - Agdamag, Arianne C AU - Agdamag AC AUID- ORCID: 0000-0002-2948-039 AD - From the Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, Minnesota. FAU - Kalra, Rajat AU - Kalra R AUID- ORCID: 0000-0002-6293-8104 AD - From the Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, Minnesota. FAU - Nzemenoh, Bellony N AU - Nzemenoh BN AD - Department of Medicine, University of Minnesota, Minneapolis, Minnesota. FAU - Charpentier, Victoria AU - Charpentier V AUID- ORCID: 0000-0002-9712-3677 AD - University of Minnesota, Medical School, Minneapolis, Minnesota. FAU - Bartos, Jason A AU - Bartos JA AUID- ORCID: 0000-0003-0113-5305 AD - From the Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, Minnesota. AD - Center for Resuscitation Medicine, University of Minnesota, Minneapolis, Minnesota. FAU - Brunsvold, Melissa E AU - Brunsvold ME AUID- ORCID: 0000-0003-4044-1591 AD - Division of Critical Care/Acute Care Surgery, University of Minnesota, Minneapolis, Minnesota. FAU - Yannopoulos, Demetris AU - Yannopoulos D AD - From the Department of Medicine, Division of Cardiology, University of Minnesota, Minneapolis, Minnesota. AD - Center for Resuscitation Medicine, University of Minnesota, Minneapolis, Minnesota. LA - eng PT - Journal Article DEP - 20220207 PL - United States TA - ASAIO J JT - ASAIO journal (American Society for Artificial Internal Organs : 1992) JID - 9204109 SB - IM CIN - ASAIO J. 2023 Feb 1;69(2):e110-e111. PMID: 35609186 CIN - ASAIO J. 2023 Feb 1;69(2):e109. PMID: 35749753 MH - *COVID-19/complications/therapy MH - Death MH - *Extracorporeal Membrane Oxygenation/adverse effects MH - Humans MH - *Respiratory Insufficiency/etiology/therapy MH - Retrospective Studies MH - SARS-CoV-2 MH - *Ventricular Dysfunction, Right/complications/therapy PMC - PMC9148640 COIS- Disclosure: Jason A. Bartos and Demetris Yannopoulos received philanthropic grants for resuscitation and ECMO research from NIH. The remaining authors have no conflicts of interest to report. EDAT- 2022/06/02 06:00 MHDA- 2022/06/07 06:00 PMCR- 2022/02/07 CRDT- 2022/06/01 16:13 PHST- 2022/06/01 16:13 [entrez] PHST- 2022/06/02 06:00 [pubmed] PHST- 2022/06/07 06:00 [medline] PHST- 2022/02/07 00:00 [pmc-release] AID - 00002480-202206000-00005 [pii] AID - 10.1097/MAT.0000000000001666 [doi] PST - ppublish SO - ASAIO J. 2022 Jun 1;68(6):772-778. doi: 10.1097/MAT.0000000000001666. Epub 2022 Feb 7.